H

Hangzhou Biotest Biotech Co Ltd
SSE:688767

Watchlist Manager
Hangzhou Biotest Biotech Co Ltd
SSE:688767
Watchlist
Price: 37.01 CNY -2.76% Market Closed
Market Cap: ¥5.5B

Operating Margin

13.1%
Current
Improving
by 0.9%
vs 3-y average of 12.1%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
13.1%
=
Operating Income
¥62.6m
/
Revenue
¥478.7m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
13.1%
=
Operating Income
¥62.6m
/
Revenue
¥478.7m

Peer Comparison

Country Company Market Cap Operating
Margin
CN
Hangzhou Biotest Biotech Co Ltd
SSE:688767
5.5B CNY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
395.2B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.2B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
175.6B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
77.9B USD
Loading...
AU
CSL Ltd
ASX:CSL
87.8B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.3B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Higher than 77% of companies in China
Percentile
77th
Based on 8 544 companies
77th percentile
13.1%
Low
-409 046.1% — -1.4%
Typical Range
-1.4% — 10.3%
High
10.3% — 876.4%
Distribution Statistics
China
Min -409 046.1%
30th Percentile -1.4%
Median 4.2%
70th Percentile 10.3%
Max 876.4%

Hangzhou Biotest Biotech Co Ltd
Glance View

Market Cap
5.5B CNY
Industry
Biotechnology

Hangzhou Biotest Biotech Co., Ltd. engages in the research and development, production and sales of point-of-care testing (POCT) diagnostic reagents. The company is headquartered in Hangzhou, Zhejiang and currently employs 622 full-time employees. The company went IPO on 2021-09-08. The firm's products include reproductive health testing series, such as human chorionic gonadotropin testing reagent and luteinizing hormone testing reagent, and drug abuse testing series, such as morphine testing reagent and cocaine testing reagent, and infectious disease testing series, such as adenovirus testing reagent and typhoid antibody testing reagent, and tumor marker testing series, such as alpha fetoprotein detection reagent, and myocardial marker detection series, such as dimer detection reagent and myocardial series detection reagent.

Intrinsic Value
20.58 CNY
Overvaluation 44%
Intrinsic Value
Price
H
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
13.1%
=
Operating Income
¥62.6m
/
Revenue
¥478.7m
What is Hangzhou Biotest Biotech Co Ltd's current Operating Margin?

The current Operating Margin for Hangzhou Biotest Biotech Co Ltd is 13.1%, which is above its 3-year median of 12.1%.

How has Operating Margin changed over time?

Over the last 3 years, Hangzhou Biotest Biotech Co Ltd’s Operating Margin has decreased from 48.6% to 13.1%. During this period, it reached a low of -22.1% on Sep 30, 2023 and a high of 48.6% on Aug 30, 2022.

Back to Top